Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
Joined April 2009
104 Following 10.5M Followers
Revolution Medicines secured US regulatory approval for its pancreatic cancer drug daraxonrasib, the first medicine to target one of the key molecular causes of the disease
